eFFECTOR Therapeutics Announces $8.7M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Portfolio Pulse from Benzinga Newsdesk
eFFECTOR Therapeutics announced an $8.7 million registered direct offering priced at-the-market under Nasdaq rules.
June 07, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
eFFECTOR Therapeutics (EFTR) announced an $8.7 million registered direct offering, which may impact its stock price.
eFFECTOR Therapeutics announced an $8.7 million registered direct offering priced at-the-market under Nasdaq rules. This news may impact the stock price of EFTR, as it indicates the company is raising capital. However, the short-term impact is uncertain, as the market may react positively or negatively to the news.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100